Autism. Autistic disorder
Conditions
Interventions
Intervention 1: Intervention group: L-carnitine powder at the dose of 50 mg/kg/day for 8 weeks. Intervention 2: Control group: Placebo powder(Sodium bicarbonate based) at the dose of 50 mg/kg/day for
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 16 Years
Inclusion criteria
Inclusion criteria: 3 to 16 years old IQ level above severe mental retardation autism diagnosed based on DSM 5
Exclusion criteria
Exclusion criteria: Schizophrenia and psychotic disorders History of drug or alcohol abuse History of tardive dyskinesia Neuroleptic drugs use or any psychotic medical treatment in the past 6 months Known cases of medical diseases such as diabetes, respiratory diseases and asthma, renal diseases, hematologic disorders and... Having aneurism or hematoma Severe mental retardation Taking anticonvulsant or antihypertensive drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Behavioral symptoms, cognitive, social and physical health. Timepoint: Baseline, 4th week, 8th week. Method of measurement: ABC Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Extrapyramidal symptoms. Timepoint: Baseline, 4th week, 8th week. Method of measurement: ESRS Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDanial Jelvani
Esfahan University of Medical Sciences
Outcome results
None listed